Compositions of ezetimibe and methods for the treatment of cholesterol-associated benign and malignant tumors

Details for Australian Patent Application No. 2003254261 (hide)

International Classifications

Event Publications

30 October 2003 Complete Application Filed

Priority application(s): 10/630,578 30.07.03 US; 60/399,690 30.07.02 US

25 March 2004 Application Open to Public Inspection

Published as AU-B-2003254261

26 May 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant from The Children's Medical Center Corporation to Children's Medical Center Corporation

17 April 2008 Application Accepted

Published as AU-B-2003254261

14 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.